SOLUBLE INTERLEUKIN-33 RECEPTOR (sST-2)- A NOVEL MARKER FOR ASSESSING CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Patschan, S. [1 ]
Claus, I. [1 ]
Hoffmeister, M. [2 ]
Remus, C. [3 ]
Ritter, O. [3 ]
Patschan, D. [1 ]
机构：
[1] Brandenburg Med Sch Theodor Fontane, Dept Internal Med 1, Brandenburg, Germany
[2] Brandenburg Med Sch Theodor Fontane, Inst Biochem, Brandenburg, Germany
[3] Brandenburg Med Sch Theodor Fontane, Dept Internal Med 1, Brandenburg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷
关键词：
Disease-modifying Drugs (DMARDs); Biomarkers;
D O I：
10.1136/annrheumdis-2024-eular.4728
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0607
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PLEURAL FLUID SOLUBLE INTERLEUKIN-2 RECEPTOR IN RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    PETTERSSON, T
    SODERBLOM, T
    NYBERG, P
    TISKA, H
    LINKO, L
    KLOCKARS, M
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (10) : 1820 - 1824
  • [32] Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritis
    Spadaro, A
    Riccieri, V
    Scavalli, AS
    Sensi, E
    Taccari, E
    Zoppini, A
    CLINICAL RHEUMATOLOGY, 1996, 15 (02) : 218 - 219
  • [33] Plasma levels of interleukin-33 (IL-33) and soluble suppression of tumorigenicity 2 (sST2) as a potential predictive biomarker in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC) undergoing systemic chemotherapy (sCTX)
    Kieler, M.
    Unseld, M.
    Demyanets, S.
    Bianconi, D.
    Prager, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] SERIAL SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN RHEUMATOID-ARTHRITIS - DIFFERENCES IN RESPONSE TO GLUCOCORTICOID TREATMENT AND CHRYSOTHERAPY
    KIRKHAM, BW
    DAVISON, SC
    CORKILL, MM
    BARBATIS, C
    PANAYI, GS
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (06) : 935 - 939
  • [35] SOLUBLE INTERLEUKIN-2 RECEPTOR - ELEVATED LEVELS IN SERUM AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    CARPENTER, AB
    EISENBEIS, CH
    CARRABIS, S
    BROWN, MC
    IP, SH
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1990, 4 (02) : 130 - 134
  • [36] ELEVATED SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN THE SERA AND SYNOVIAL-FLUIDS OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    KEYSTONE, EC
    SNOW, KM
    BOMBARDIER, C
    CHANG, CH
    NELSON, DL
    RUBIN, LA
    ARTHRITIS AND RHEUMATISM, 1988, 31 (07): : 844 - 849
  • [37] Tumour necrosis factor-α, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis
    Fröde, TS
    Tenconi, P
    Debiasi, MR
    Medeiros, YS
    MEDIATORS OF INFLAMMATION, 2002, 11 (06) : 345 - 349
  • [38] RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH THE INTERLEUKIN-6 RECEPTOR INHIBITOR TOCILIZUMAB
    Rao, Vijay Udyavar
    Pavlov, Andrey
    Klearman, Micki
    Musselman, David
    Giles, Jon
    Bathon, Joan M.
    Sattar, Naveed
    Lee, Janet S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1648 - E1648
  • [39] SERUM CONCENTRATIONS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN PATIENTS WITH RHEUMATOID-ARTHRITIS - EFFECT OF 2ND LINE DRUGS
    CRILLY, A
    MADHOK, R
    WATSON, J
    CAPELL, HA
    ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (01) : 58 - 60
  • [40] Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis
    Spadaro, A
    Taccari, E
    Riccieri, V
    Sensi, F
    Scavalli, AS
    Zoppini, A
    REVUE DU RHUMATISME, 1997, 64 (02): : 89 - 94
12345